The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Purpose
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression
Condition
- Treatment Resistant Depression
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Diagnosis of TRD
Exclusion Criteria
- Other comorbidities
Study Design
- Phase
- Phase 2
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Low dose |
Low dose Psilocybin |
|
Experimental Medium dose |
Medium dose Psilocybin |
|
Experimental High dose |
High dose Psilocybin |
|
Recruiting Locations
More Details
- NCT ID
- NCT03775200
- Status
- Completed
- Sponsor
- COMPASS Pathways
Detailed Description
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression - a dose-ranging study